{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:24:01Z","timestamp":1785306241226,"version":"3.55.0"},"reference-count":50,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.3201\/eid2608.191547","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T13:16:43Z","timestamp":1593523003000},"page":"1767-1777","source":"Crossref","is-referenced-by-count":23,"title":["Increased Sensitivity of <i>Plasmodium falciparum<\/i> to Artesunate\/Amodiaquine Despite 14 Years as First-Line Malaria Treatment, Zanzibar"],"prefix":"10.3201","volume":"26","author":[{"given":"Mwinyi","family":"Msellem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aungpaing","family":"Soe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza B.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Wahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Frumento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2608.191547-202007161914-R1","unstructured":"World Health Organization. World malaria report, 2018 [cited 2020 May 26]. https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/en"},{"key":"key-10.3201\/eid2608.191547-202007161914-R2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-018-1243-z","article-title":"From high to low malaria transmission in Zanzibar-challenges and opportunities to achieve elimination.","volume":"17","author":"Bj\u00f6rkman","year":"2019","journal-title":"BMC Med"},{"key":"key-10.3201\/eid2608.191547-202007161914-R3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia.","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","article-title":"Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.","volume":"17","author":"WWARN K13 Genotype-Phenotype Study Group","year":"2019","journal-title":"BMC Med"},{"key":"key-10.3201\/eid2608.191547-202007161914-R5","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1056\/NEJMc1713777","article-title":"Evidence of artemisinin-resistant Plasmodium falciparum malaria in eastern India.","volume":"379","author":"Das","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2608.191547-202007161914-R6","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/infdis\/jiv752","article-title":"Independent emergence of the Plasmodium falciparum Kelch propeller domain mutant allele C580Y in Guyana.","volume":"213","author":"Chenet","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0035-9203(90)90246-B","article-title":"The epidemiology of drug-resistant malaria.","volume":"84","author":"Bj\u00f6rkman","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid2608.191547-202007161914-R8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","article-title":"Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y.","volume":"6","author":"Holmgren","year":"2006","journal-title":"Infect Genet Evol"},{"key":"key-10.3201\/eid2608.191547-202007161914-R9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.meegid.2007.03.005","article-title":"Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.","volume":"7","author":"Holmgren","year":"2007","journal-title":"Infect Genet Evol"},{"key":"key-10.3201\/eid2608.191547-202007161914-R10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).","volume":"191","author":"Sisowath","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2608.191547-202007161914-R12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1473-3099(18)30047-1","article-title":"Asymptomatic low-density malaria infections: a parasite survival strategy?","volume":"18","author":"Bj\u00f6rkman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R14","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1365-3156.2009.02289.x","article-title":"Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania.","volume":"14","author":"Beer","year":"2009","journal-title":"Trop Med Int Health"},{"key":"key-10.3201\/eid2608.191547-202007161914-R15","doi-asserted-by":"publisher","first-page":"e1000070","DOI":"10.1371\/journal.pmed.1000070","article-title":"Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation study.","volume":"6","author":"Msellem","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2608.191547-202007161914-R16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10928-007-9064-2","article-title":"Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria.","volume":"34","author":"Hietala","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"key-10.3201\/eid2608.191547-202007161914-R17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/650301","article-title":"In vivo parasitological measures of artemisinin susceptibility.","volume":"201","author":"Stepniewska","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1475-2875-12-103","article-title":"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance\/resistance in Bagamoyo district, Tanzania.","volume":"12","author":"Malmberg","year":"2013","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4269\/ajtmh.16-0780","article-title":"Sustained high cure rate of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria after 8 years of its wide-scale use in Bagamoyo District, Tanzania.","volume":"97","author":"Mwaiswelo","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2608.191547-202007161914-R20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/444460","article-title":"Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.","volume":"41","author":"M\u00e5rtensson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.meegid.2015.04.018","article-title":"Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013.","volume":"33","author":"Morris","year":"2015","journal-title":"Infect Genet Evol"},{"key":"key-10.3201\/eid2608.191547-202007161914-R22","unstructured":"World Health Organization. Guidelines for the treatment of malaria, 3rd ed. Geneva: The Organization; 2015."},{"key":"key-10.3201\/eid2608.191547-202007161914-R23","unstructured":"WWARN. Worldwide Antimalarial Resistance Network (WWARN) Explorer [cited 2019 Oct 15]. https:\/\/www.wwarn.org\/tracking-resistance\/wwarn-explorer"},{"key":"key-10.3201\/eid2608.191547-202007161914-R24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"key-10.3201\/eid2608.191547-202007161914-R25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0010-4825(98)00047-X","article-title":"Exact 95% confidence intervals for differences in binomial proportions.","volume":"29","author":"Fagan","year":"1999","journal-title":"Comput Biol Med"},{"key":"key-10.3201\/eid2608.191547-202007161914-R26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","article-title":"In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria.","volume":"120","author":"Folarin","year":"2011","journal-title":"Acta Trop"},{"key":"key-10.3201\/eid2608.191547-202007161914-R27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12936-018-2440-0","article-title":"Efficacy of artesunate-amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar.","volume":"17","author":"Raobela","year":"2018","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/1475-2875-13-439","article-title":"Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in C\u00f4te d\u2019Ivoire.","volume":"13","author":"Toure","year":"2014","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12936-016-1430-3","article-title":"Adding a single low-dose of primaquine (0.25\u00a0mg\/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.","volume":"15","author":"Mwaiswelo","year":"2016","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-015-0301-z","article-title":"The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.","volume":"13","author":"Adjuik","year":"2015","journal-title":"BMC Med"},{"key":"key-10.3201\/eid2608.191547-202007161914-R31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pt.2009.12.007","article-title":"The perils of PCR: can we accurately \u2018correct\u2019 antimalarial trials?","volume":"26","author":"Juliano","year":"2010","journal-title":"Trends Parasitol"},{"key":"key-10.3201\/eid2608.191547-202007161914-R32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1086\/510910","article-title":"Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.","volume":"195","author":"Martensson","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R33","first-page":"e01500","article-title":"Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphism markers.","volume":"61","author":"Messerli","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2608.191547-202007161914-R34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12879-017-2530-6","article-title":"Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.","volume":"17","author":"Zwang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R35","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/infdis\/jit431","article-title":"Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.","volume":"208","author":"Beshir","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2608.191547-202007161914-R36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ebiom.2017.10.003","article-title":"Detection of malaria parasites after treatment in travelers: a 12-months longitudinal study and statistical modelling analysis.","volume":"25","author":"Vafa Homann","year":"2017","journal-title":"EBioMedicine"},{"key":"key-10.3201\/eid2608.191547-202007161914-R37","doi-asserted-by":"publisher","first-page":"26330","DOI":"10.1038\/srep26330","article-title":"Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda.","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid2608.191547-202007161914-R38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijpddr.2012.01.001","article-title":"Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?","volume":"2","author":"Cheng","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"key-10.3201\/eid2608.191547-202007161914-R39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12936-019-2645-x","article-title":"An online mapping database of molecular markers of drug resistance in Plasmodium falciparum: the ACT Partner Drug Molecular Surveyor.","volume":"18","author":"Otienoburu","year":"2019","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1475-2875-13-284","article-title":"Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.","volume":"13","author":"Mishra","year":"2014","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1475-2875-12-255","article-title":"Selection of pfdhfr\/pfdhps alleles and declining artesunate\/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.","volume":"12","author":"Gadalla","year":"2013","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1128\/AAC.00950-12","article-title":"Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro.","volume":"57","author":"Fr\u00f6berg","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2608.191547-202007161914-R43","doi-asserted-by":"publisher","first-page":"20153038","DOI":"10.1098\/rspb.2015.3038","article-title":"Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum.","volume":"283","author":"Bushman","year":"2016","journal-title":"Proc Biol Sci"},{"key":"key-10.3201\/eid2608.191547-202007161914-R44","doi-asserted-by":"publisher","first-page":"e02731","DOI":"10.1128\/mBio.02731-18","article-title":"Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness.","volume":"10","author":"Dhingra","year":"2019","journal-title":"MBio"},{"key":"key-10.3201\/eid2608.191547-202007161914-R45","doi-asserted-by":"publisher","first-page":"e00172","DOI":"10.1128\/mBio.00172-17","article-title":"Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro.","volume":"8","author":"Straimer","year":"2017","journal-title":"MBio"},{"key":"key-10.3201\/eid2608.191547-202007161914-R46","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa062032","article-title":"Return of chloroquine antimalarial efficacy in Malawi.","volume":"355","author":"Laufer","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2608.191547-202007161914-R47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4269\/ajtmh.2003.68.413","article-title":"Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi.","volume":"68","author":"Mita","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2608.191547-202007161914-R48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12936-020-3137-8","article-title":"Falciparum malaria from coastal Tanzania and Zanzibar remains highly connected despite effective control efforts on the archipelago.","volume":"19","author":"Morgan","year":"2020","journal-title":"Malar J"},{"key":"key-10.3201\/eid2608.191547-202007161914-R49","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1128\/AAC.00252-10","article-title":"Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.","volume":"54","author":"Hietala","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2608.191547-202007161914-R50","doi-asserted-by":"publisher","first-page":"e4551","DOI":"10.1371\/journal.pone.0004551","article-title":"Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.","volume":"4","author":"Carrara","year":"2009","journal-title":"PLoS One"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/26\/8\/19-1547_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:34:46Z","timestamp":1732988086000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/26\/8\/19-1547_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2608.191547","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}